SOTIO exercises option on ADC program
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first…
November 30, 2022 - 2 minutes
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first…
This week, we have four interviews: Franjo Hanzl, vice president commercial development Europe at Eversana;…
SOTIO Biotech has presented preclinical results of its BOXR T cell therapy platform and revealed…